EA can reduce the formation of cofilin rod and the degradation of MAP2, inhibit the cleavage of mitochondrial cofilin and caspase-3, significantly reduce the apoptosis and loss of neurons after ischemic stroke, thus enhancing the recovery of nerve function and reducing brain injury and infarct volume. This evidence concerns the gene MAP2 and ischemic stroke.